- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Coagulation Protein Disorder
Total 162822 results
-
RTI InternationalEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsEnrolling by invitationPrimary Hyperoxaluria Type 3 | Diabetes Mellitus | Hemophilia A | Hemophilia B | Hereditary Fructose Intolerance | Cystic Fibrosis | Factor VII Deficiency | Phenylketonurias | Sickle Cell Disease | Dravet Syndrome | Duchenne Muscular Dystrophy | Prader-Willi Syndrome | Fragile X Syndrome | Chronic Granulomatous Disease and other conditionsUnited States
-
Federico II UniversityCompleted
-
TakedaCompleted
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia BSpain, United Kingdom, Australia, Taiwan, France, Malaysia, United States, Austria, Canada, Israel, Japan, Thailand, Algeria, Argentina
-
Genzyme, a Sanofi CompanyActive, not recruitingHemophiliaChina, Hungary, Turkey, Canada, Korea, Republic of, United States, Australia, Denmark, France, Germany, India, Ireland, Israel, Italy, Japan, Malaysia, South Africa, Taiwan, Ukraine, United Kingdom
-
Baxalta now part of ShireActive, not recruitingHemophilia ASpain, Thailand, Hungary, Taiwan, Korea, Republic of, Czechia, Germany, Sweden, Italy, Croatia, United States, Bulgaria, Netherlands
-
HaemnetBioMarin PharmaceuticalCompleted
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.Completed
-
Swedish Orphan BiovitrumCompletedHaemophilia A | Haemophilia BSweden, Finland, Denmark
-
PfizerActive, not recruitingHemophilia ASpain, Taiwan, Australia, United States, Japan, France, Turkey, Germany, Korea, Republic of, United Kingdom, Saudi Arabia, Canada, Greece, Sweden, Brazil, Italy
-
TakedaTakeda Pharma Korea Co. Ltd.Completed
-
Spark TherapeuticsCompletedHematologic Diseases | Blood Coagulation Disorders, Inherited | Coagulation Protein Disorders | Hemorrhagic Disorders | Genetic Diseases, Inborn | Genetic Diseases, X-Linked | Gene Therapy | Blood Coagulation Disorder | Gene Transfer | Adeno-Associated Virus (AAV) | Factor VIII (FVIII) | Factor VIII (FVIII)... and other conditionsUnited States
-
Bioverativ, a Sanofi companyCompletedHemophilia ATurkey, Australia, Canada, France, Germany, Hungary, Ireland, Italy, Netherlands, Spain, Sweden, Switzerland, Taiwan, United Kingdom, United States
-
Novo Nordisk A/SEnrolling by invitationHaemophilia ADenmark
-
Novo Nordisk A/SEnrolling by invitationHaemophilia BCanada, United Kingdom, Czechia, Germany, Greece, Austria, Belgium, Croatia, Denmark, Finland, Norway, Portugal
-
Genzyme, a Sanofi CompanyActive, not recruitingHemophiliaCanada, Italy, Turkey, Spain, United States, India
-
Novo Nordisk A/SEnrolling by invitationHaemophilia BNetherlands, United Kingdom
-
Swedish Orphan BiovitrumCerner EnvizaCompleted
-
Swedish Orphan BiovitrumCerner EnvizaCompletedHemophilia A With InhibitorFrance, Ireland, Italy, Norway, Germany, Kuwait, Saudi Arabia, Switzerland
-
Swedish Orphan BiovitrumCerner EnvizaActive, not recruitingHemophilia BCzechia, Greece, Ireland, Italy, Norway, Saudi Arabia, Spain, Sweden, United Kingdom
-
Swedish Orphan BiovitrumCerner EnvizaCompleted
-
Baxalta now part of ShireActive, not recruiting
-
American Thrombosis and Hemostasis NetworkGenentech, Inc.Active, not recruitingHemophilia A With Inhibitor | Hemophilia B With Inhibitor | Haemophilia A Without Inhibitor | Haemophilia B Without InhibitorUnited States
-
American Thrombosis and Hemostasis NetworkTakedaActive, not recruiting
-
Eli Lilly and CompanySigilon Therapeutics, Inc.TerminatedHemophilia AUnited Kingdom, United States
-
Spark TherapeuticsActive, not recruitingHemophilia AUnited States, Canada, Australia
-
Radboud University Medical CenterActive, not recruitingAortic Valve Stenosis | Aortic Valve Insufficiency | Transcatheter Aortic Valve Replacement | Hemodynamic Monitoring | Acquired Von Willebrand Disease | Heyde's SyndromeNetherlands
-
Spark TherapeuticsCompletedHemophilia AUnited States, Australia, Canada, Israel, Thailand
-
Radboud University Medical CenterActive, not recruiting
-
Emory UniversityGenentech, Inc.Withdrawn
-
TakedaAvailableVon Willebrand Disease (VWD)
-
Staidson (Beijing) Biopharmaceuticals Co., LtdBeijing Novikang Medical Technology Co., LTDCompleted
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsUnited States
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsUnited States
-
Novo Nordisk A/SEnrolling by invitationHaemophilia AAustria, Spain, Bulgaria, Croatia, Estonia, Hungary, Italy, Lithuania, Portugal, Greece, Germany, Czechia, Slovenia, Switzerland, Slovakia
-
Swedish Orphan BiovitrumIQVIA Pvt. LtdTerminatedHemophilia A | Hemophilia BBulgaria, Croatia, Czechia, France, Hungary, Ireland, Italy, Romania, Slovenia, Spain, United Kingdom
-
TakedaCompletedVon Willebrand Disease (VWD)Canada
-
BioMarin PharmaceuticalActive, not recruitingHemophilia AUnited States, Taiwan, United Kingdom, Australia, Israel, Belgium, Brazil, France, Germany, Italy, Korea, Republic of, South Africa, Spain
-
BioMarin PharmaceuticalActive, not recruiting
-
Zhengzhou Gensciences IncHaimen Gensciences lncCompleted
-
The League of Clinical Research, RussiaCompletedHemophilia ARussian Federation
-
OctapharmaCompletedVon Willebrand DiseasesLebanon, Croatia, United States, Hungary, Russian Federation, Ukraine, Belarus, Bulgaria
-
BayerCompletedHaemophilia ASpain, Russian Federation, United States, Hungary, Italy, Mexico, Norway, Romania, Bulgaria, Canada, Argentina, Denmark, Israel, Poland, Ireland, Latvia, Lithuania
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SEnrolling by invitation
-
AryoGen Pharmed Co.CompletedSevere Hemophilia AIran, Islamic Republic of